VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices for workplace safety and law enforcement, is pleased to announce the first commercial sales of its Marijuana Breath Test (“MBT”) products into the construction industry. The products were sold to a major construction company located in the Pacific Northwest through an authorized reseller. ...

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $32.8 million, a 25% increase from $26.2 million in Q3 2025, driven by improved capital spending and new product sales [12][4] - Gross margin expanded to 45.4%, up 350 basis points sequentially from 41.9% in Q3 2025, reflecting higher sales of new products and improved operating leverage [13][14] - Net income for Q4 was $1.2 million, with an adjusted EBITDA of $3.2 million, representing an adjusted EBITDA margin of 9.7% [17][18] Business Line Data and Key Metrics Changes - Revenue increases in Q4 were led by industrial ($3.3 million), defense aerospace ($3.2 million), life sciences ($2.1 million), and auto/EV ($1 million), while semi revenue declined by $2.9 million [12][16] - Life sciences orders tripled sequentially in Q4, reflecting strong bookings for new Alfamation products, while semi orders increased by 18% sequentially [9][10] Market Data and Key Metrics Changes - Non-semi revenues have grown at approximately 20% CAGR over the past five years, indicating successful market diversification [8] - Life sciences orders were up 137% year-over-year, auto EV orders increased by 89%, and industrial orders rose by 53% [9][10] Company Strategy and Development Direction - The company is focused on diversifying its revenue streams, with nearly 80% of Q4 revenue derived from non-semi end markets, aligning with its VISION 2030 goal of generating 25% of revenue from new products [7][25] - The establishment of a manufacturing hub in Malaysia and an expanded European footprint are part of the strategy to enhance customer relationships and capitalize on long-term opportunities [25][26] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism for 2026, expecting a gradual recovery in capital spending and a healthy backlog of $53.9 million, with 60% expected to ship beyond Q1 2026 [20][22] - The company anticipates revenue growth of approximately 12% in 2026, driven by diversified demand in industrial, aerospace, defense, auto EV, and life sciences [22][23] Other Important Information - The company reduced total debt by $1.4 million in Q4 and by $7.6 million in 2025, ending the year with approximately $58 million in liquidity [19] - Operating expenses for Q4 were $13.6 million, reflecting a reduction in operating expenses as a percentage of revenue to 41.5% [16] Q&A Session Summary Question: Semi space outlook and guidance - Management indicated that guidance reflects a modest recovery in the semi space, which could be conservative, and they are well positioned to capture growth if it materializes [31] Question: Progress on automotive programs - The automotive sector has shown positive trends, with customers moving forward on 2027 model year programs, and the company is well positioned to support these initiatives [32][34] Question: Strength in life sciences orders - Life sciences have been a bright spot, with significant success in the medtech space, particularly with new products from Alfamation [35][36] Question: Back-end test positioning - The company is well positioned in the back-end test space, with new products broadening the customer base and preparing for growth as investments in testing increase [43] Question: Silicon carbide space outlook - Management is optimistic about the silicon carbide space, expecting growth to return in 2027, with some potential recovery in the second half of 2026 [45][47] Question: Gross margins and future guidance - Management noted that while semi contributes higher margins, the current focus is on maintaining strong margins through operational efficiencies and product mix [53][54] Question: Bookings activity and momentum - The company has seen strong bookings activity, particularly in the automotive sector, and expects healthy order levels moving forward [61][62] Question: Operating expenses and incentive compensation - Management confirmed that guidance includes considerations for reinstating variable compensation as performance improves [64]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $32.8 million, a 25% increase from $26.2 million in Q3 2025, driven by improved capital spending and new product sales [12] - Gross margin expanded to 45.4% in Q4 2025, up from 41.9% in Q3 2025, reflecting higher sales of new products and improved operating leverage [13][14] - Net income for Q4 2025 was $1.2 million, with an adjusted EBITDA of $3.2 million, representing an adjusted EBITDA margin of 9.7% [17] Business Line Data and Key Metrics Changes - Revenue from industrial markets increased by $3.3 million, defense aerospace by $3.2 million, life sciences by $2.1 million, and auto/EV by about $1 million in Q4 2025 [12] - Life sciences orders tripled sequentially in Q4 2025, reflecting strong bookings for new Alfamation products [9] - Semi orders were up about 18% sequentially, but represented only 25% of total orders in Q4 2025, down from 40% in Q4 2024 [10] Market Data and Key Metrics Changes - Non-semi revenues grew at approximately 20% CAGR over the past five years, indicating successful market diversification [8] - Life sciences orders increased by 137% year-over-year, auto EV orders were up 89%, and industrial orders increased by 53% [9] - The backlog at year-end 2025 was $53.9 million, a 36% increase year-over-year, with 60% expected to ship beyond Q1 2026 [10] Company Strategy and Development Direction - The company is focused on revenue diversification and new product innovation as key pillars of its VISION 2030 growth strategy [6][24] - The establishment of a manufacturing hub in Malaysia and an expanded European footprint are aimed at better serving customers and deepening relationships in key regions [24] - The goal is to generate 25% of revenue from new products by 2030, with current trends indicating progress towards this target [25] Management's Comments on Operating Environment and Future Outlook - Management noted that customer hesitation to spend on capital projects was driven by tariff and macroeconomic uncertainties, but demand is expected to recover gradually [4][20] - The company anticipates 2026 will be a year of returning growth, with revenue guidance of $125 million to $130 million, reflecting a 12% increase over 2025 [22] - There is cautious optimism regarding the semiconductor market, with expectations for modest recovery but not heavily relying on it for growth [20][58] Other Important Information - Operating expenses for Q4 2025 were $13.6 million, an increase of $1.4 million sequentially, primarily due to higher sales commissions and marketing activity [16] - The company reduced debt by $1.4 million in Q4 2025, ending the year with approximately $58 million in liquidity [19] Q&A Session Summary Question: Insights on the semiconductor space and guidance - Management indicated that guidance reflects a modest recovery in the semiconductor market, which could be conservative, but they are well-positioned to capture growth if it materializes [28][29] Question: Progress on automotive programs - The automotive sector has shown positive trends, with customers moving forward with 2027 model year programs, and the company is well-positioned to support these initiatives [31] Question: Growth in life sciences - Life sciences have been a bright spot, with significant success in the medtech space, particularly with new products from Alfamation [34][35] Question: Positioning in back-end and front-end semiconductor testing - The company is well-positioned in back-end testing and has launched new products that broaden their customer base, anticipating growth as investments in testing spaces increase [42][43] Question: Guidance on gross margins and potential for improvement - Management acknowledged that while current margins are strong, a recovery in the semiconductor market could lead to further margin improvements, potentially approaching historical levels [54][56] Question: Bookings activity and momentum - The company reported strong bookings activity, particularly in the automotive sector, and expects healthy order levels moving forward [62] Question: Operating expenses and incentive compensation - Management confirmed that guidance includes considerations for reinstating variable compensation and incentives as performance improves [65]

Morgan Stanley sets a price target of $288 for Teradyne, Inc. (NASDAQ:TER), indicating a modest increase.Teradyne reports impressive fourth-quarter results, with adjusted earnings of $1.80 per share and revenue of $1.08 billion.The company anticipates significant growth in 2026, driven by strong demand in the compute and memory sectors, fueled by AI.Teradyne, Inc. (NASDAQ:TER) is a leading supplier of automation equipment for test and industrial applications. The company is known for its advanced testing so ...

Core Insights - Keysight Technologies, Inc. (KEYS) has partnered with Point2 Technology to address connectivity challenges in hyperscale AI data centers by testing next-generation, multi-terabit interconnects [1] Group 1: Partnership and Technology Development - Keysight will utilize its high-speed digital test solutions, including the M8050A High-Performance Bit Error Ratio Tester (BERT) and DCA-X Sampling Oscilloscopes, to evaluate Point2's e-Tube technology [2] - The collaboration enables Keysight to generate and analyze complex 120 GBaud PAM4 signals necessary for achieving ultra-fast 1.6-terabit data speeds, thereby enhancing advanced testing and interconnect technologies [3] - Keysight is also engaged in early research on 3.2T interfaces using its 448 Gbps signal generation and advanced testing tools [2][3] Group 2: Strategic Collaborations - Keysight is collaborating with NVIDIA Corporation (NVDA) to advance hybrid quantum and AI computing by integrating high-performance control systems with AI-driven infrastructure [4] Group 3: Competitive Landscape - Keysight faces competition from Viavi Solutions Inc. (VIAV) and Teradyne, Inc. (TER), with Viavi working on a test system for Open RAN products and Teradyne partnering with MultiLane for advanced test solutions [5][6] Group 4: Financial Performance and Valuation - Keysight's shares have increased by 29.7% over the past year, compared to the industry's growth of 35.1% [7] - The company's shares are currently trading at a forward 12-month earnings multiple of 26.53, which is lower than the industry average of 30.93 [10] - Earnings estimates for Keysight for 2026 have risen by 1.1% to $8.03, while estimates for 2027 have increased by 2.1% to $9.25 over the past 60 days [11]

Market Reactions - The CEO of Indonesia's stock market, Imam Rachman, resigned, leading to a 1.2% gain in Jakarta's benchmark index, which had previously been at all-time highs but fell 7.4% on Wednesday and 1.1% on Thursday due to MSCI's warning about market risks [1][14] - The Hang Seng index in Hong Kong dropped 1.8% to 27,455.13, while the Shanghai Composite index slipped 0.9% to 4,122.61 [1][14] - Tokyo's Nikkei 225 fell 0.1% to 53,322.85, with declines in artificial intelligence-related stocks, including a 4.5% drop for Advantest and a 1.7% drop for Disco Corp [4][14] - South Korea's Kospi edged up 0.1% to 5,224.36 after initial talks with U.S. Commerce Secretary Howard Lutnick did not yield an agreement [4][14] U.S. Stock Market Performance - U.S. stocks experienced modest movements, with the S&P 500 slipping 0.1% after reaching record highs earlier in the day and dropping by as much as 1.5% [5][14] - Microsoft saw a significant decline of 10%, marking its worst day since the COVID crash in 2020, despite reporting stronger-than-expected profits and revenue [5][14] - Tesla's stock fell 3.5%, delivering a profit that exceeded analyst expectations but was lower than the previous year [6][14] Precious Metals and Currency Trends - Gold prices decreased by 2.8% to $5,205 per ounce after briefly reaching near $5,600, having nearly doubled over the last 12 months [7][14] - Silver prices declined 4.1% to nearly $110.41, following a significant upward trend [7][14] - The U.S. dollar traded at 153.85 Japanese yen, up from 152.97 yen, while the euro slipped to $1.1921 from $1.1967 [9][14] Oil Market Dynamics - Oil prices fell after a previous increase of over 3% due to concerns about U.S.-Iran tensions affecting crude flow [10][14] - U.S. benchmark crude oil lost $1.07 to $64.35 per barrel, while Brent crude dropped $1.10 to $68.49 per barrel [11][14]

Core Viewpoint - Investors with significant capital have adopted a bearish stance on Teradyne (NASDAQ:TER), indicating potential upcoming changes in the company's outlook [1][2]. Options Trading Activity - Benzinga's options scanner identified 19 options trades for Teradyne, suggesting that large investors may have insights into future developments [2]. - The sentiment among big-money traders is mixed, with 42% bullish and 47% bearish positions noted. Specifically, there was 1 put option totaling $25,950 and 18 call options amounting to $2,010,983 [3]. - The projected price targets for Teradyne, based on volume and open interest, range from $80.0 to $240.0 over the past quarter [4]. Volume and Open Interest Analysis - Analyzing the volume and open interest of options is crucial for understanding liquidity and interest in Teradyne's options. Recent data shows significant whale trades within the strike price range of $80.0 to $240.0 over the last 30 days [5]. Noteworthy Options Activity - A detailed snapshot of options activity reveals bearish sentiment in several trades, with notable call options at strike prices of $150.00 and $240.00, indicating a cautious outlook among traders [9]. Company Overview - Teradyne specializes in testing equipment, including automated test equipment for semiconductors and industrial automation solutions, serving various end markets with a strong focus on semiconductor testing [10]. Current Market Position - Professional analysts have set an average price target of $260.0 for Teradyne, reflecting a generally positive outlook despite the current bearish sentiment in options trading [12]. - The current stock price of Teradyne is $234.84, up 2.02%, with upcoming earnings expected in 18 days. Analysts from B of A Securities and Stifel maintain Buy ratings with target prices of $250 and $270, respectively [14].

Group 1 - The era of humanoid robots capable of work is approaching, with institutions highlighting that the mass production capability of core components will be a decisive factor for investment success. Key companies have been identified [1] - Testing equipment is set to benefit from AI computing power, advanced packaging, and structural opportunities in automotive electronics, with a focus on core domestic replacement targets [1] - An AI industry conference is imminent, presenting a window for investment in two core tracks [1] - The industry is entering a concentrated period of benefits realization, with brain-computer interface commercialization accelerating [1]

Core Insights - Three companies from Suzhou High-tech Zone Shishan Business Innovation District have been selected as provincial enterprise technology centers for 2025, which are crucial for building technological innovation systems and enhancing competitive market positions [1] Company Summaries - Suzhou Lianxun Instrument Co., Ltd. has achieved key technological breakthroughs in optical communication testing, power device testing, and semiconductor integrated circuit testing [1] - Suzhou Haipeng Technology Co., Ltd. focuses on distributed photovoltaic inverter products and smart energy management solutions, with products sold in over 70 countries across five continents [1] - Suzhou Gaiya Information Technology Co., Ltd. has developed core technologies for real-time parallel processing of massive data and dynamic scheduling algorithms for heterogeneous data, serving clients in 34 countries and regions with over 7 million employees using its services daily [1]

Core Insights - Cannabix Technologies Inc. has developed an autonomous alcohol breathalyzer screening device called BreathLogix, aimed at various industries and safety settings [1][10] - The company has received its first international product orders for BreathLogix from its exclusive distribution partner in Australia, Breathalyser Sales & Service Pty Ltd [1][2] Product Overview - BreathLogix devices provide rapid breath alcohol checks, capture user photos, and deliver real-time alerts to managers, enhancing workplace safety by preventing alcohol-related injuries [2][6] - The devices feature patent-pending pre-calibrated sensor cartridge technology, allowing for easy maintenance without costly calibration equipment [7] Distribution Agreement - Cannabix entered into an exclusive distribution agreement with Breathalyser SSP for Australia, New Zealand, and the Pacific Islands, leveraging Breathalyser SSP's extensive experience in the alcohol testing market [2][3] - Breathalyser SSP is a leading distributor in Australia, serving various sectors including mining, oil and gas, and technology [3] Company Statements - The CEO of Cannabix expressed excitement about the first orders from Australia, highlighting the company's commitment to delivering innovative technologies [4] - The Managing Director of Breathalyser SSP emphasized the key features of BreathLogix that are important to employers, such as rapid testing and cloud reporting capabilities [4] Financial Update - Cannabix will not proceed with a previously announced non-brokered private placement, indicating a reassessment of capital requirements in early 2026 due to recent orders and increased distribution activity [8]